Pricing Log in Create free account

Janux Therapeutics, Inc. (JANX) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

Janux Therapeutics, Inc. and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. Janux Therapeutics, Inc. and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.1B and $1.1B). Nanobiotix S.A. - Sponsored ADR has the higher net margin (0.00% vs −427.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Janux Therapeutics, Inc. leads on 7 and Nanobiotix S.A. - Sponsored ADR on 6.

Valuation

Metric JANX NBTX Biotechnology median
P/E n/m n/m 8.50
P/S 43.24 4,254.38 9.71
P/B 1.12 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.79 3,498.88 9.21
Earnings yield (9.95%) (15.59%) (33.15%)
Free cash flow yield (4.04%) (19.65%) (25.50%)

Profitability

Metric JANX NBTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (598.15%) 0.00% 0.00%
Net margin (427.47%) 0.00% 0.00%
Free cash flow margin (174.69%) 0.00% 0.00%
Return on equity (10.70%) 0.00% (56.36%)
Return on assets (10.06%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric JANX NBTX Biotechnology median
Revenue growth (TTM) 83.92% — 6.02%
EPS growth (last fiscal year) (42.97%) 63.46% 30.26%
Revenue growth, 5-year CAGR — 66.64% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JANX NBTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.35 1.44 4.72
Net debt to EBITDA 5.58 5.66 0.96

Dividend

Metric JANX NBTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JANX NBTX Biotechnology median
Market cap 1.06b 1.13b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack